FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Regentis Biomaterials Ltd. Stock AnalysisComprehensive stock analysis for Regentis Biomaterials Ltd. (RGNT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRGNT
RGNT
Regentis Biomaterials Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RGNT
Home🔹Stocks🔹Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd.

RGNT•AMEX

Regentis Biomaterials Ltd.

RGNT•AMEX
Market cap
$7.01M
Sentiment

Your view on RGNT

Mkt Cap
$7.01M
Sentiment
Your view
RGNT
Regentis Biomaterials Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RGNT
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Regentis Biomaterials Ltd.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Eli Hazum
Headquarters
IL
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Eli Hazum
Headquarters
IL
Description

Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions that restore the health and enhance quality of life of patients. Its lead product candidate is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries and articular knee cartilage. The company focuses on developing orthopedic treatments using its Gelrin platform that is based on degradable hydrogel implants to regenerate damaged or diseased tissue. Regentis Biomaterials Ltd. was incorporated in 2004 and is based in Herzliya, Israel.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News